Sidley Life Sciences Briefing
Switzerland Expands Integrity Rules to Medical Devices: Key Compliance Implications for Medtech Companies
August 2026
Switzerland is preparing to extend its integrity and anti-inducement rules to the medical device sector, significantly expanding compliance obligations for medtech companies operating in the Swiss market. The proposed revision would bring manufacturers, distributors, hospital procurement functions, and healthcare professionals within scope of a stricter regulatory framework governing commercial interactions involving medical devices.
Offices
関連公式ブログ
得意分野
Suggested News & Insights
Sidley Healthcare Investment Conference 2026Tuesday, September 22, 2026Swiss MedTech 2026Tuesday, August 25, 2026Through the Looking Glass: What WHA79 Reveals About the Future of Global Life SciencesAugust 2026Recent ESG Developments in EuropeAugust 2026Sidley Represents SlateView Capital in Joint Venture Formation and Acquisition of Meadowbrook at Agoura Hills in Southern CaliforniaAugust 18, 2026Sidley Advises on Janus Living’s US$533.6 Million Public OfferingAugust 14, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory


